Dillard's (DDS) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
5 Dec, 2025Executive summary
Sales strength continued through Q3 2025, with total and comparable retail sales up 3% year-over-year and retail gross margin improving by 80 basis points to 45.3%.
Net income for the quarter was $129.8 million ($8.31 per share), up from $124.6 million ($7.73 per share) in Q3 2024.
For the 39 weeks, net income was $366.5 million ($23.39 per share), slightly down from $379.1 million ($23.42 per share) year-over-year.
Cash flow from operations for the nine months ended November 1, 2025, was $505.9 million, a significant increase from $349.4 million in the prior year period.
The company operated 272 stores and an internet store as of November 1, 2025.
Financial highlights
Q3 2025 net sales were $1.47 billion, up from $1.43 billion in Q3 2024; nine-month net sales reached $4.51 billion, up from $4.47 billion year-over-year.
Retail gross margin for Q3 2025 was 45.3% of sales, up from 44.5% last year.
SG&A expenses rose to 30.0% of sales in Q3 2025 from 29.4% in Q3 2024, mainly due to higher payroll costs.
Cash and cash equivalents at quarter-end were $1.15 billion, with total debt of $521.6 million.
Earnings per share for the nine months were $23.39, nearly flat year-over-year.
Outlook and guidance
Fiscal 2025 federal and state effective income tax rate is expected to approximate 19%, reflecting tax benefits from a special dividend.
The company expects to finance operations through cash on hand, operating cash flow, and available credit.
Remaining construction contract obligations are expected to be satisfied over the next 9–18 months.
Estimates for the 52-week period ending January 31, 2026: depreciation and amortization $180 million, rentals $20 million, net interest income $7 million, capital expenditures $100 million.
Latest events from Dillard's
- Merger approved with no shareholder dilution, maintaining governance and proportional ownership.DDS
Proxy filing20 Mar 2026 - Stable annual results with strong cash position and record dividend, despite Q4 sales dip.DDS
Q4 202624 Feb 2026 - Director nominee Warren A. Stephens resigned; board seat to remain vacant until replacement elected.DDS
Proxy Filing2 Dec 2025 - Shareholders are voting on reincorporation to Texas, aiming for legal, tax, and governance benefits.DDS
Proxy Filing2 Dec 2025 - 2025 proxy covers director elections, auditor ratification, pay-for-performance, and governance.DDS
Proxy Filing2 Dec 2025 - Proposal seeks shareholder approval to reincorporate from Delaware to Texas, preserving rights and reducing risk.DDS
Proxy Filing2 Dec 2025 - Director elections and auditor ratification headline the May 2025 annual meeting agenda.DDS
Proxy Filing2 Dec 2025 - Q2 2025 retail sales rose 1% with strong cash flow, stable EPS, and ongoing share repurchases.DDS
Q2 20255 Sep 2025 - Net income and sales fell, but gross margin stayed strong and a $25 dividend was declared.DDS
Q3 202413 Jun 2025